| Application no. and date | 09718951.8 (espacenet) (Federated) (European Patent Register), 20090312 | | Patent/reg. no. and date | DK/EP 2262505, 20140910 | | Publication date | 20101222 | | Priority no. and date | US 36069 P, 20080312 | | EP pub. no. and date |
EP 2262505 20101222 | | Effective date | | | Applicant/owner | Intra-Cellular Therapies, Inc., 3960 Broadway
New York, NY 10032, US | | Applicant ref. no. | V105847 | | Inventor | WENNOGLE, Lawrence, P., Intra-Cellular Therapies Inc.
3960 Broadway
New York, NY 10032, US,
TOMESCH, John, Intra-Cellular Therapies Inc
3960 Broadway
New York, NY 10032, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/55 (2006.01) , C07D 471/16 (2006.01) | | Title | SUBSTITUERET HETEROCYKLUS-KONDENSERET GAMMA-CARBOLIN-FASTSTOF | | Int. application no. | US2009001608 | | Int. publication no. | WO2009114181 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
